ES2183734A1 - Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos. - Google Patents

Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Info

Publication number
ES2183734A1
ES2183734A1 ES200101818A ES200101818A ES2183734A1 ES 2183734 A1 ES2183734 A1 ES 2183734A1 ES 200101818 A ES200101818 A ES 200101818A ES 200101818 A ES200101818 A ES 200101818A ES 2183734 A1 ES2183734 A1 ES 2183734A1
Authority
ES
Spain
Prior art keywords
bipyridyl
bisthiazole
bisoxazole
proliferation
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200101818A
Other languages
English (en)
Other versions
ES2183734B1 (es
Inventor
Sanchez-Cantalejo Yolan Martin
Hormaeche Maria Jesus Villa
Pizarro Beatriz Saez
Romero Javier Soto
Brana Miguel Fernandez
Sanjuan Juan Carlos Lacal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Europea de Madrid SA
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Europea de Madrid SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Universidad Europea de Madrid SA filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES200101818A priority Critical patent/ES2183734B1/es
Publication of ES2183734A1 publication Critical patent/ES2183734A1/es
Application granted granted Critical
Publication of ES2183734B1 publication Critical patent/ES2183734B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Derivados de 4-4''-Bipiridil-2-2''-Bisoxazoles y 4-4''-Bipiridil-2- 2''-Bistiazoles como agentes antineoplásicos. La presente invención presenta nuevos derivados de 4-4''-bipiridil-2-2''- bisoxazoles y 4-4''-bipiridil-2-2''-bistiazoles de fórmula general I con actividad antiproliferativa, y concretamente, de células malignas como HT-29. Por otro lado, se indica en la presente patente el mecanismo de su producción industrial y su uso para el desarrollo de compuestos farmacéuticos para el tratamiento de tumores humanos.
ES200101818A 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos. Expired - Fee Related ES2183734B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200101818A ES2183734B1 (es) 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101818A ES2183734B1 (es) 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Publications (2)

Publication Number Publication Date
ES2183734A1 true ES2183734A1 (es) 2003-03-16
ES2183734B1 ES2183734B1 (es) 2004-06-16

Family

ID=8498615

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101818A Expired - Fee Related ES2183734B1 (es) 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Country Status (1)

Country Link
ES (1) ES2183734B1 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122417A2 (en) * 1983-03-18 1984-10-24 American Cyanamid Company Polymeric(((oxazolidinyl)alkyl)amino)anthraquinones
WO2001044241A1 (en) * 1999-12-15 2001-06-21 Bristol-Myers Squibb Co. N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122417A2 (en) * 1983-03-18 1984-10-24 American Cyanamid Company Polymeric(((oxazolidinyl)alkyl)amino)anthraquinones
WO2001044241A1 (en) * 1999-12-15 2001-06-21 Bristol-Myers Squibb Co. N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DESAI, SUNIL B. y col. SYNTHESIS OF SOME SCHIFF BASES, THIAZOLIDINONES AND AZETIDINONES DERIVED FROM 2,6-DIAMINOBENZO[1,2-d:4,5-d']BISTHIAZOLE AND THEIR ANTICANCER ACTIVITIES. Heterocyclic Communications, Mayo 2001, Vol. 7, Nö 1, páginas 83-90, ISSN 0793-0283. *
KOSARY, J. y col. Synthesis of pyridylthiazoles as antisecretory agents. Pharmazie, 1989, Vol. 44, Nö 3, páginas 191-193. Compuestos con RN 121608-76-2, 121608-79-5, 121633-13-4 y 121633-14-5. *
RICE, CRAIG R. y col. New multidentate ligands for supramolecular coordination chemistry: double and triple helical complexes of ligands containing pyridyl and thiazolyl donor units. J. Chem. Soc., Dalton Trans., Marzo 2001, Vol. 5, pßginas 550-559, ISSN 1472-7773. Compuestos con RN 341521-28-6 y 341521-26-4; pßgina 551, esquema 1. *

Also Published As

Publication number Publication date
ES2183734B1 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
EP1487413A4 (en) INHALATION SYSTEM FOR THE TREATMENT OF INTRACELLULAR INFECTIONS
WO2004028454A3 (en) 1, 3, 5-triazines for treatment of viral diseases
TR200201442T2 (tr) Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.
EP1381280A4 (en) VIRAL VECTORS AND USE THEREOF IN THERAPEUTIC METHODS
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
ZA200500323B (en) Use of lkb kinase inhibitors for the treatment of pain.
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
GB0121490D0 (en) Ciompounds
PT967987E (pt) Composicoes para o tratamento de tumores contendo extractos de cartilagem de tubarao e agentes antineoplasicos
ZA984463B (en) Fused dihydropyrans
IL159887A0 (en) Combination therapy for the treatment of cancer
MX9707022A (es) Derivados de fenilo trisustituidos.
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2002367172A1 (en) 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
YU82503A (sh) Upotreba antagonista neuronskih natrijumovih kanala za kontrolu ektoparazita kod toplokrvnih životinja
WO2003084611A8 (en) Depsipeptide for therapy of kidney cancer
MXPA03010323A (es) Compuestos y metodos para inhibir el mal olor axilar.
MXPA03006776A (es) Uso de inhibidores de interleucina-18 para el tratamiento y/o prevencion de enfermedad cardiaca.
PL348828A1 (en) New cancer treatments
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
GB0121494D0 (en) Compounds
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ES2183734A1 (es) Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030316

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2183734B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807